Scarica l'app Stockscreener
15.80
8.30%
-1.43
Dopo l'orario di chiusura:
15.92
0.12
+0.76%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHVN Giù?
Forum
Previsione
Precedente Chiudi:
$17.23
Aprire:
$17.55
Volume 24 ore:
2.29M
Relative Volume:
1.05
Capitalizzazione di mercato:
$1.67B
Reddito:
-
Utile/perdita netta:
$-766.97M
Rapporto P/E:
-2.0627
EPS:
-7.66
Flusso di cassa netto:
$-646.43M
1 W Prestazione:
-0.06%
1M Prestazione:
+12.78%
6M Prestazione:
-7.76%
1 anno Prestazione:
-69.29%
Intervallo 1D:
$15.71
$17.61
Intervallo di 1 settimana:
$14.98
$17.61
Portata 52W:
$12.79
$54.98
Biohaven Ltd Stock (BHVN) Company Profile
Nome
Biohaven Ltd
Settore
Industria
Telefono
203-404-0410
Indirizzo
215 CHURCH STREET, NEW HAVEN, CT
Confronta BHVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
15.80 | 1.82B | 0 | -766.97M | -646.43M | -7.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Iniziato | Citigroup | Buy |
| 2025-09-03 | Iniziato | Raymond James | Strong Buy |
| 2025-05-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-09-16 | Iniziato | Jefferies | Buy |
| 2024-09-04 | Iniziato | Bernstein | Outperform |
| 2024-07-24 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2023-12-22 | Iniziato | H.C. Wainwright | Buy |
| 2023-12-08 | Iniziato | Robert W. Baird | Outperform |
| 2023-01-24 | Iniziato | SVB Securities | Outperform |
| 2023-01-04 | Iniziato | JP Morgan | Overweight |
| 2022-12-02 | Iniziato | BTIG Research | Buy |
| 2022-10-26 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | Iniziato | Piper Sandler | Overweight |
| 2022-08-19 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-05-11 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-08-10 | Downgrade | UBS | Buy → Neutral |
| 2021-08-03 | Reiterato | Canaccord Genuity | Buy |
| 2021-03-11 | Iniziato | UBS | Buy |
| 2020-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-17 | Iniziato | Cowen | Outperform |
| 2020-02-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-02-06 | Iniziato | Mizuho | Buy |
| 2019-11-22 | Iniziato | Wedbush | Outperform |
| 2019-06-25 | Reiterato | Canaccord Genuity | Buy |
| 2019-05-06 | Iniziato | Goldman | Buy |
| 2019-04-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | Reiterato | Needham | Buy |
| 2018-07-03 | Reiterato | Needham | Buy |
| 2018-07-02 | Reiterato | Needham | Buy |
| 2018-04-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-02-22 | Reiterato | Canaccord Genuity | Buy |
| 2017-12-15 | Iniziato | Canaccord Genuity | Buy |
| 2017-10-03 | Reiterato | Needham | Buy |
Mostra tutto
Biohaven Ltd Borsa (BHVN) Ultime notizie
Will Biohaven Ltd. stock pay special dividends2025 Retail Activity & Weekly High Momentum Picks - newser.com
How to recover losses in Biohaven Ltd. stockQuarterly Market Review & Weekly Return Optimization Plans - newser.com
Biohaven (NYSE:BHVN) Trading 7% HigherStill a Buy? - MarketBeat
Weiss Ratings Reaffirms "Sell (E+)" Rating for Biohaven (NYSE:BHVN) - MarketBeat
Pfizer settles Biohaven kickback case with DOJ for $60M - MSN
Leading vs lagging indicators on Biohaven Ltd. performanceWeekly Trade Review & Capital Protection Trading Alerts - newser.com
Will Biohaven Ltd. see short term momentumWeekly Gains Report & Risk Controlled Swing Alerts - newser.com
Will Biohaven Ltd. Common Shares stock outperform energy sector in 2025Quarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Should Biohaven's (BHVN) Accelerating Cash Burn and Shorter Runway Require Action From Investors? - simplywall.st
New Haven startup Bexorg uses donated brains to reshape drug discovery - Hartford Business Journal
Biohaven (NYSE:BHVN) Trading Down 4.6%Here's Why - MarketBeat
A Look at Biohaven (BHVN) Valuation as Cash Runway Narrows and Funding Concerns Grow - simplywall.st
Biohaven Ltd.’s volatility index tracking explainedQuarterly Portfolio Summary & Fast Moving Stock Watchlists - newser.com
Biohaven Ltd. stock trend forecastIndex Update & Reliable Intraday Trade Plans - newser.com
Published on: 2025-10-06 07:41:08 - newser.com
Published on: 2025-10-05 05:51:51 - newser.com
Is Biohaven Ltd. Common Shares stock a contrarian opportunityQuarterly Profit Summary & Smart Money Movement Alerts - newser.com
Biohaven Ltd. recovery potential after sell off2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
Sentiment analysis tools applied to Biohaven Ltd.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Regression analysis insights on Biohaven Ltd. performanceStop Loss & Short-Term High Return Strategies - newser.com
What indicators show strength in Biohaven Ltd.Long Setup & Real-Time Chart Breakout Alerts - newser.com
Is Biohaven Ltd. stock a good choice for value investorsRisk Management & Free Community Consensus Stock Picks - newser.com
Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy” - MSN
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Published on: 2025-09-29 05:11:50 - newser.com
Biohaven Ltd Azioni (BHVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Biohaven Ltd Azioni (BHVN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Car Bruce | Chief Scientific Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
4,750 |
0 |
7,133 |
| Gentile Kimberly | SVP, Clinical Operations |
Jan 05 '25 |
Option Exercise |
0.00 |
3,750 |
0 |
99,719 |
| Clark George C. | VP, Chief Accounting Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
66,168 |
| Buten Matthew | Chief Financial Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
4,250 |
0 |
196,013 |
| Coric Vlad | Chief Executive Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
14,250 |
0 |
1,803,409 |
| CHILDS JOHN W | Director |
Dec 30 '24 |
Buy |
35.94 |
29,000 |
1,042,393 |
2,368,741 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):